Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis: A Randomized Trial.

Conclusions In sepsis, PCT-guidance was effective in reducing infection-associated adverse events, 28-day mortality, and cost of hospitalization. Clinical trial registration available at www.clinicaltrials.gov, ID: NCT03333304. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). PMID: 32757963 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32757963?dopt=Abstract

Source: American Journal of Respiratory and Critical Care Medicine - August 5, 2020 Category: Respiratory Medicine Authors: Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, Marousis K, Chrysos G, Spyrou A, Alexiou N, Symbardi S, Alexiou Z, Lagou S, Kolonia V, Gkavogianni T, Kyprianou M, Anagnostopoulos I, Poulakou G, Lada M, Makkina A, Tags: Am J Respir Crit Care Med Source Type: research